Frier Levitt invites you to explore the latest edition of our Healthcare Newsletter, a comprehensive resource delivering insights and updates into the ever-evolving world of healthcare law. We are committed to keeping you informed, and this edition is packed with critical developments to help you navigate the nuances of healthcare regulations.
In this edition, we cover pressing industry topics, including:
- NEW YORK CLIENT ALERT: Effective October 20th, 2024, New York State to Ban Obtaining Patient Consent to Payment Prior to Treatment
- HRSA Issues Letter to Johnson & Johnson to Cease Implementation of Its Proposed 340B Rebate Model
- NJ Supreme Court Clarifies Limited Scope of Privilege Under Patient Safety Act (PSA)
- CAPITATED PROVIDER ALERT: Beware Relationships, Direct or Indirect, With Insurance Agents and Brokerages Seeking to Increase Your Patient Membership Size
- Upcoming CMS Reporting Requirements: Act Now to Ensure Compliance with Ownership Disclosures
- DMEPOS Supplier Alert: Even Inadvertent Surety Bond Lapses May Lead to Revocation of Medicare Billing Privileges and Lengthy Re-Enrollment Bars
- Federal Judge Orders Company Compounding Tirzepatide To Stop Eli Lilly Trademark Infringement
- UPTICK IN ENFORCEMENT: Mental Health Providers Dealing with Allegations of the “Impossible Day” Scenario
- Senator Letters Question Manufacturer Direct-to-Consumer Telehealth Programs
- Power in Numbers: The Importance of Coalition-Building to Advocate for Change
The newsletter also features external publications by Frier Levitt attorneys, recent client success stories, and a practice spotlight on our Government Investigations, Litigation & White-Collar Defense Group.
Additionally, gain access to upcoming and on-demand webinars, designed to keep you ahead of the curve and provide you with the tools necessary to succeed in the complex healthcare landscape.
